Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study
Clinical trial NCT07514052 · RECRUITING
Trial details
- NCT number
- NCT07514052
- Sponsor
- Shanxi Bethune Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-01
- Primary completion
- 2027-01-31
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.